These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1722753)
1. Reduction in brain serotonin markers by alpha-ethyltryptamine (Monase). Huang XM; Johnson MP; Nichols DE Eur J Pharmacol; 1991 Jul; 200(1):187-90. PubMed ID: 1722753 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain. Fattaccini CM; Gozlan H; Hamon M Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793 [TBL] [Abstract][Full Text] [Related]
3. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits. Sprague JE; Nichols DE J Pharmacol Exp Ther; 1995 May; 273(2):667-73. PubMed ID: 7538579 [TBL] [Abstract][Full Text] [Related]
4. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Colado MI; Murray TK; Green AR Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129 [TBL] [Abstract][Full Text] [Related]
5. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment. Dewar KM; Grondin L; Carli M; Lima L; Reader TA J Neurochem; 1992 Jan; 58(1):250-7. PubMed ID: 1370077 [TBL] [Abstract][Full Text] [Related]
6. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region. Dewar KM; Reader TA; Grondin L; Descarries L Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575 [TBL] [Abstract][Full Text] [Related]
7. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission. Andrews AM; Murphy DL J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the striatum. Sprague JE; Nichols DE Psychopharmacology (Berl); 1995 Apr; 118(3):357-9. PubMed ID: 7542394 [TBL] [Abstract][Full Text] [Related]
9. Serotonergic effects of isatin: an endogenous MAO inhibitor related to tribulin. McIntyre IM; Norman TR J Neural Transm Gen Sect; 1990; 79(1-2):35-40. PubMed ID: 1688707 [TBL] [Abstract][Full Text] [Related]
10. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor. Hewton R; Salem A; Irvine RJ Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093 [TBL] [Abstract][Full Text] [Related]
11. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain. Savage DD; Mendels J; Frazer A J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637 [TBL] [Abstract][Full Text] [Related]
12. Studies on the mechanism of p-chloroamphetamine neurotoxicity. Sprague JE; Johnson MP; Schmidt CJ; Nichols DE Biochem Pharmacol; 1996 Oct; 52(8):1271-7. PubMed ID: 8937435 [TBL] [Abstract][Full Text] [Related]
13. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats. Nash JF; Arora RC; Schreiber MA; Meltzer HY Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633 [TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity. Johnson M; Stone DM; Bush LG; Hanson GR; Gibb JW Eur J Pharmacol; 1989 Feb; 161(2-3):181-8. PubMed ID: 2470597 [TBL] [Abstract][Full Text] [Related]
15. Behavioral, biochemical and neurotoxicological actions of the alpha-ethyl homologue of p-chloroamphetamine. Johnson MP; Huang XM; Oberlender R; Nash JF; Nichols DE Eur J Pharmacol; 1990 Nov; 191(1):1-10. PubMed ID: 1982656 [TBL] [Abstract][Full Text] [Related]
16. Release of 3H-5-hydroxytryptamine by amiflamine and related phenylalkylamines from rat occipital cortex slices. Ask AL; Fagervall I; Huang RB; Ross SB Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):684-9. PubMed ID: 2770890 [TBL] [Abstract][Full Text] [Related]
17. Serotonergic hyperinnervation of the frontal cortex in an animal model of depression, the bulbectomized rat. Zhou D; Grecksch G; Becker A; Frank C; Pilz J; Huether G J Neurosci Res; 1998 Oct; 54(1):109-16. PubMed ID: 9778154 [TBL] [Abstract][Full Text] [Related]
18. Newly synthesized noradrenaline mediates the alpha 2-adrenoceptor inhibition of [3H]5-hydroxytryptamine release induced by beta-phenylethylamine in rat hippocampal slices. Benkirane S; Arbilla S; Langer SZ Eur J Pharmacol; 1986 Nov; 131(2-3):189-98. PubMed ID: 3028829 [TBL] [Abstract][Full Text] [Related]
19. Neurochemical changes in the rat brain after intraventricular administration of tryptamine-4,5-dione. Chen JC; Schnepper PW; To A; Volicer L Neuropharmacology; 1992 Mar; 31(3):215-9. PubMed ID: 1378572 [TBL] [Abstract][Full Text] [Related]
20. Effects of idebenone on metabolism of monoamines and cyclic AMP formation in rats. Nagai Y; Narumi S; Kakihana M; Yamazaki N; Nagaoka A; Nagawa Y Arch Gerontol Geriatr; 1989 May; 8(3):273-89. PubMed ID: 2475075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]